Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-20

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for donepezil hydrochloride, a generic Alzheimer's disease medication, submitted by Unichem Pharmaceuticals (USA), Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)